The Apelinergic System in Kidney Disease: Novel Perspectives
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms27010111 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sara Saladich-Cavallé und 8 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology and Transplantation Research Group, Vall d'Hebrón Research Institute (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Ho…. Hauptthemen laut MEDLINE: Apelin, Renal Insufficiency, Chronic, Apelin Receptors. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boehringer Ingelheim, Instituto de Salud Carlos III, China Scholarship Council (CSC).
Abstract (Originalsprache)
Chronic kidney disease (CKD) is a major complication of diabetes, affecting approximately 30–40% of patients. In many cases, CKD progresses to end-stage renal disease (ESRD). The peptide apelin and its receptor, APLNR, which is expressed in the endothelial cells of renal blood vessels, play a key role in glucose uptake and the regulation of vasodilation in the afferent and efferent glomerular arterioles. Numerous studies have demonstrated that the apelinergic system is dysregulated in various pathologies, including CKD in people with diabetes. In recent years, the apelinergic system has emerged as a promising therapeutic target for several diseases, with various apelin analogs and inhibitors being developed. In this review, we summarize the most recent literature on apelin and its cellular mechanisms of action, highlighting the role of the apelinergic system in various pathologies and its impact on patients with CKD and diabetes. Additionally, we explore the currently available analogs and inhibitors and discuss their potential therapeutic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nephrology and Transplantation Research Group, Vall d'Hebrón Research Institute (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
- Nephrology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
- Clinical Biochemistry, Drug Delivery and Therapy Research Group, Vall d'Hebrón Research Institute (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.
ORCID-Profile: Frederic Pons-Pellicer, Irene Martínez-Díaz, Conxita Jacobs-Cachá, Sheila Bermejo, Maria José Soler
Förderung
- Boehringer Ingelheim
- Instituto de Salud Carlos III
- China Scholarship Council (CSC)
- RICORS2040 network
- Catalan Management Agency for University and Research Grants
Zitieren
APA
Saladich-Cavallé, S., Núñez-Delgado, S., Huo, L., Pons-Pellicer, F., Martínez-Díaz, I., Jacobs-Cachá, C., Bermejo, S., Vilardell-Vilà, J., & Soler, M. J. (2025). The Apelinergic System in Kidney Disease: Novel Perspectives. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010111
Vancouver
Saladich-Cavallé S, Núñez-Delgado S, Huo L, Pons-Pellicer F, Martínez-Díaz I, Jacobs-Cachá C, et al. The Apelinergic System in Kidney Disease: Novel Perspectives. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms27010111
BibTeX
@article{SaladichCavall2025,
author = {Saladich-Cavallé, Sara and Núñez-Delgado, Sara and Huo, Linhui and Pons-Pellicer, Frederic and Martínez-Díaz, Irene and Jacobs-Cachá, Conxita and Bermejo, Sheila and Vilardell-Vilà, Jordi and Soler, Maria José},
title = {The Apelinergic System in Kidney Disease: Novel Perspectives},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms27010111}
}
EUVIMED